Health and Healthcare

Amgen : AMGN

All Amgen Articles

707 Articles

Jon C. Ogg | Jun 4, 2019 at 11:10 AM EDT

Credit Suisse Calls Out Amgen as Its Key Cancer Winner From ASCO

Amgen is the largest of all biotechs now, and it is being deemed an "ASCO winner" for cancer and oncology…

Chris Lange | May 28, 2019 at 8:35 AM EDT

Major Biotechs See a Rising Tide in Short Interest

The May 15 short interest data have been compared with the previous report, and short interest in most of these…

Jon C. Ogg | May 23, 2019 at 11:40 AM EDT

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and…

Jon C. Ogg | May 23, 2019 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

The top analyst upgrades, downgrades and initiations seen on Thursday included AK Steel, Amgen, Booking, Chubb, Chipotle Mexican Grill, Expedia,…

Chris Lange | May 21, 2019 at 9:05 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors…

Chris Lange | May 10, 2019 at 8:55 AM EDT

Short Sellers Back Off Major Biotechs

The April 30 short interest data have been compared with the previous report, and short interest in most of these…

Chris Lange | Apr 26, 2019 at 9:40 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The April 15 short interest data have been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Apr 24, 2019 at 12:55 PM EDT

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top…

Lee Jackson | Apr 23, 2019 at 7:40 AM EDT

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Jefferies did a deep dive into the health care sector, looking for underperforming stocks that could hold some solid value…

Chris Lange | Apr 10, 2019 at 9:15 AM EDT

Big Biotechs Confound Short Sellers

The March 29 short interest data have been compared with the previous report, and short interest moves in these selected…

Chris Lange | Mar 27, 2019 at 8:30 AM EDT

Big Biotechs Scare Off Short Sellers

The March 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 12, 2019 at 9:05 AM EDT

Major Biotechs See a Rising Tide in Short Interest

The February 28 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Feb 28, 2019 at 8:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data…

Trey Thoelcke | Feb 22, 2019 at 8:00 AM EST

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a…

Chris Lange | Feb 12, 2019 at 9:55 AM EST

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data…

1 … 13 14 15 16 17 … 48

Amgen : AMGN

All Amgen Articles

Credit Suisse Calls Out Amgen as Its Key Cancer Winner From ASCO

Major Biotechs See a Rising Tide in Short Interest

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

Short Sellers Back Off Major Biotechs

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Big Biotechs Confound Short Sellers

Big Biotechs Scare Off Short Sellers

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Short Sellers Run for Cover From Major Biotechs

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

A Caller’s Dad Turned $22,000 Into $1 Million on a Single Stock. Now the Family Faces a $150,000 Tax Decision

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

Amgen : AMGN

All Amgen Articles

Credit Suisse Calls Out Amgen as Its Key Cancer Winner From ASCO

Major Biotechs See a Rising Tide in Short Interest

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

Short Sellers Back Off Major Biotechs

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Big Biotechs Confound Short Sellers

Big Biotechs Scare Off Short Sellers

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Short Sellers Run for Cover From Major Biotechs

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

A Caller’s Dad Turned $22,000 Into $1 Million on a Single Stock. Now the Family Faces a $150,000 Tax Decision

Featured Reads

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60